Welcome to the Cannabis Investing Newsletter Forum. Feel free to find your favorite cannabis stocks and contribute content as you please; content that continues the discussion of and analysis of cannabis stocks. – D. H. Taylor
Options and Restricted Shares
TORONTO, Nov. 23, 2021 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces the award of stock options ("Options") and restricted share units ("RSUs") under the Company's amended and restated restricted share unit plans approved by shareholders at the annual general and special meeting of shareholders held on September 10, 2020.
On November 23, 2021, the board of directors granted a total of 1,400,000 Options and 950,000 RSUs to certain officers of the Company. Certain of the Options and RSUs are subject to performance-based vesting conditions. The Options are exercisable at a price of $0.75 per share and will expire on November 23, 2026. Unvested RSUs will expire on December 15, 2024.